SNY logo

SNY
Sanofi-Aventis

5,821
Mkt Cap
$112.29B
Volume
3.68M
52W High
$55.77
52W Low
$43.32
PE Ratio
19.51
SNY Fundamentals
Price
$46.78
Prev Close
$46.62
Open
$47.50
50D MA
$46.34
Beta
0.29
Avg. Volume
5.22M
EPS (Annual)
$2.41
P/B
1.35
Rev/Employee
$643,658.13
$134,040.08
Loading...
Loading...
News
all
press releases
Sanofi Reports Positive Phase 3 Results For Amlitelimab In Atopic Dermatitis
(RTTNews) - Sanofi SA (SNY, SNYNF,SAN.PA) announced encouraging results from three Phase 3 clinical trialsCOAST 1, COAST 2, and SHOREevaluating amlitelimab, a fully human non-T cell depleting monoclonal antibody that selectively targets OX40-ligand (OX40L). The studies, present...
Nasdaq News: Markets·22h ago
News Placeholder
More News
News Placeholder
Dynamic Advisor Solutions LLC Decreases Stock Holdings in Sanofi $SNY
Dynamic Advisor Solutions LLC reduced its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 87.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,290 shares of the company's stock after selling 52,401 shares du...
MarketBeat·1d ago
News Placeholder
Top Research Reports for Palantir, Linde and Arista Networks
Today's Research Daily features new research reports on 16 major stocks, including Palantir Technologies Inc. (PLTR), Linde plc (LIN) and Arista Networks, Inc. (ANET), as well as two micro-cap stocks, Comstock Holding Companies, Inc. (CHCI) and United Bancorp, Inc. (UBCP).
Zacks·2d ago
News Placeholder
Denali Wins FDA Nod for Hunter Syndrome Drug, Stock Up
DNLI surges after FDA approves Avlayah, its first commercial drug and a breakthrough Hunter syndrome therapy targeting the brain.
Zacks·3d ago
News Placeholder
REGN Soars 28.9% in Six Months: Is There More Upside Potential in 2026?
Regeneron's rally reflects biotech momentum as pipeline wins and Dupixent growth offset Eylea erosion amid intensifying competition.
Zacks·4d ago
News Placeholder
Bipartisan US Senators Reportedly Reach Breakthrough To Cap Insulin Prices at $35 – SNY, LLY, NVO Stocks Gain Pre-Market
The proposal needs the backing of Senate Majority Leader John Thune and the approval of President Donald Trump, the report added.
Stocktwits·4d ago
News Placeholder
DAVENPORT & Co LLC Sells 37,653 Shares of Sanofi $SNY
DAVENPORT & Co LLC lowered its position in Sanofi (NASDAQ:SNY - Free Report) by 1.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The...
MarketBeat·4d ago
News Placeholder
Recursion Pharmaceuticals Details AI-Driven Drug Pipeline, Sanofi/Roche Milestones, Runway to 2028
Recursion Pharmaceuticals (NASDAQ:RXRX) Chief Financial Officer Ben Taylor outlined the company's integrated approach to AI-enabled drug discovery and development, recent portfolio decisions...
MarketBeat·7d ago
News Placeholder
Sanofi (NASDAQ:SNY) Upgraded to Strong-Buy at Sanford C. Bernstein
Sanford C. Bernstein raised shares of Sanofi to a "strong-buy" rating in a research report on Thursday...
MarketBeat·8d ago
News Placeholder
Hudson Bay Capital Management LP Takes Position in Sanofi $SNY
Hudson Bay Capital Management LP acquired a new stake in Sanofi (NASDAQ:SNY - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 132,260 shares of the company's stock, valued at approxima...
MarketBeat·8d ago
<
1
2
...
>

Latest SNY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.